ratio-Atorvastatin recall (2014-07-08)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 35329660B | D. ratio-Atorvastatin 80 mg | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02350335 | 80 mg |
| 35330655C | B. ratio-Atorvastatin 20 mg | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02350319 | 20 mg |
| 35329657E | C. ratio-Atorvastatin 40 mg | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02350327 | 40 mg |
| 35329653E | A. ratio-Atorvastatin 10 mg | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| Tablet | DIN 02350297 | 10 mg |
Recalled products
-
ratio-Atorvastatin 10 mg
-
ratio-Atorvastatin 20 mg
-
ratio-Atorvastatin 40 mg
-
ratio-Atorvastatin 80 mg
Stability out-of-specification results at the 12-month time-point for an impurity.
Wholesalers and retailers across Canada